We have previously shown that the cell death promoting protein Bcl-2 interacting mediator of cell death (Bim) is ubiquitinated and degraded following a neuroprotection-conferring episode of brief ischemia (preconditioning). Here, we identify the E3-ligase that ubiquitinates Bim in this model, using a proteomics approach. Using phosphorylated GSTBim as bait, we precipitated and identified by mass spectrometry tri-partite motif protein 2 (TRIM2), a RING (really interesting new gene) domaincontaining protein. The reaction between TRIM2 and Bim was confirmed using co-immunoprecipitation followed by immunoblotting. We show that TRIM2 binds to Bim when it is phosphorylated by p42/p44 MAPK, but does not interact with a nonphosphorylatable Bim mutant (3ABim). Phorbol 12-myristate 13-acetate activation of p42/p44 MAPK drives Bim ubiquitination in mouse embryonic fibroblast cells, and is associated with an increased interaction between TRIM2 and Bim. One hour following preconditioning ischemia, the binding of Bim to TRIM2 increased, consistent with the time window of enhanced Bim degradation. Blocking p42/p44 MAPK activation following preconditioning ischemia with U0126 or using the nonphosphorylatable 3ABim reduced the binding between Bim and TRIM2. Immunodepletion of TRIM2 from cell lystates prepared from preconditioned cells reduced Bim ubiquitination. Finally, suppression of TRIM2 expression, using lentivirus transduction of shRNAmir, stabilized Bim protein levels and blocked neuroprotection observed in rapid ischemic tolerance. Taken together these data support a role for TRIM2 in mediating the p42/p44 MAPK-dependent ubiquitination of Bim in rapid ischemic tolerance.
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We have previously shown that the cell death promoting protein Bcl-2 interacting mediator of cell death (Bim) is ubiquitinated and degraded following a neuroprotection-conferring episode of brief ischemia (preconditioning). Here, we identify the E3-ligase that ubiquitinates Bim in this model, using a proteomics approach. Using phosphorylated GSTBim as bait, we precipitated and identified by mass spectrometry tri-partite motif protein 2 (TRIM2), a RING (really interesting new gene) domaincontaining protein. The reaction between TRIM2 and Bim was confirmed using co-immunoprecipitation followed by immunoblotting. We show that TRIM2 binds to Bim when it is phosphorylated by p42/p44 MAPK, but does not interact with a nonphosphorylatable Bim mutant (3ABim). Phorbol 12-myristate 13-acetate activation of p42/p44 MAPK drives Bim ubiquitination in mouse embryonic fibroblast cells, and is associated with an increased interaction between TRIM2 and Bim. One hour following preconditioning ischemia, the binding of Bim to TRIM2 increased, consistent with the time window of enhanced Bim degradation. Blocking p42/p44 MAPK activation following preconditioning ischemia with U0126 or using the nonphosphorylatable 3ABim reduced the binding between Bim and TRIM2. Immunodepletion of TRIM2 from cell lystates prepared from preconditioned cells reduced Bim ubiquitination. Finally, suppression of TRIM2 expression, using lentivirus transduction of shRNAmir, stabilized Bim protein levels and blocked neuroprotection observed in rapid ischemic tolerance. Taken together these data support a role for TRIM2 in mediating the p42/p44 MAPK-dependent ubiquitination of Bim in rapid ischemic tolerance.
Cerebral ischemia -the deprivation of oxygen and glucose to the brain -can result in neuronal death. However, prior exposure to a brief non-harmful dose of ischemia (preconditioning) activates an endogenous neuroprotective program, rendering the brain protected against subsequent ischemic injury (ischemic tolerance). Rapid (short-term) ischemic tolerance in brain and cultured neurons occurs one hour following a preconditioning stimulus resulting in profound neuroprotection (1, 2) .
While the exact molecular mechanisms of rapid tolerance are not fully resolved, they appear to be mediated by rapid biochemical events including activation of adenosine receptors, ATPactivated potassium channels, multiple protein kinases and the ubiquitin-proteasome system (1-7).
The ubiquitin-proteasome system rapidly degrades short-lived proteins in the cell. Ubiquitin is added to a target protein following a sequential series of reactions, whereby ubiquitin is bound first to an E1-ligase in a reaction requiring ATP. Ubiquitin is transferred to an E2-protein and then transferred via the E3-ligase to the target protein lysine residue (8) .
The HECT (Homologous to the E6-AP Carboxyl Terminus) class of E3-ligase binds to ubiquitin, prior to conjugating the ubiquitin to the target, where as the RING (really interesting new gene) containing E3-ligases appear to mediate the transfer of ubiquitin from the E2-protein directly to the target (9) . As such, the specificity of the reaction is determined by the target protein's interaction with its E3-ligase.
In our studies of rapid ischemic tolerance, we described two mechanisms whereby the ubiquitination and subsequent degradation of proteins contributes to rapid ischemic tolerance neuroprotection.
The degradation of actin binding structural proteins results in uncoupling of NMDA receptors following brief ischemia, thereby blocking excitotoxicity (6) .
In addition, we reported the apoptosis-inducing protein Bim (Bcl-2 interacting mediator of cell death) is rapidly degraded following both brief ischemia, and adenosine receptor activation in a p42/p44 MAPK dependent manner (1, 7) . Following preconditioning ischemia we observed an increase in Bim ubiquitination and a decrease in Bim protein levels, which was blocked by the proteasome inhibitor MG132 (1) . Knockdown of Bim in neurons confers protection against ischemia induced cell injury and other excitotoxic insults (1, 10) . The phosphorylation of the Ser65 (Ser69 in rat) residue by p42/p44 mitogen-activated protein kinase (p42/p44 MAPK: aka ERK 1/2 ) is a key step in the degradation of Bim (11) . Bim contains a p42/p44 MAPK binding site on its carboxyl-terminus, which facilitates its phosphorylation (11) .
The ubiquitination and degradation of Bim following preconditioning is blocked by inhibiting p42/p44 MAPK activation with U0126, an inhibitor of the upstream protein kinase MEK (1, 11) . Blocking p42/p44 MAPK activation with the Mek inhibitors U0126 and PD98059 blocks rapid ischemic tolerance (1) . Nevertheless the E3-ligase mediating the degradation of Bim in neurons following brief ischemia is unknown.
The identification of the enzyme that ubiquitinates Bim, thereby promoting its degradation (the Bim E3-ligase), would make an attractive target for anti-stroke therapy, however, the identification of the E3-ligase for Bim has proved to be a controversial matter. To date the tyrosine kinase c-Cbl (12) and CIS, a member of the SKIP-Cullen E3-ligase family, (13) have been suggested to function as a Bim E3-ligase, however, other studies suggest that c-Cbl may not mediate p42/p44 MAPK dependent Bim ubiquitination (14). Taken together, this would suggest that, at least, an additional protein may function as a Bim E3-ligase regulating MAPKdependent Bim degradation in neurons following brief ischemia.
Here we provide evidence that TRIM2 may function as the Bim E3-ligase in rapid ischemic tolerance. TRIM2 was identified as a Bim interacting protein in a proteomic study. We show in multiple systems how TRIM2 interacts with Bim, in a p42/p44 MAPKdependent manner, under conditions of enhanced Bim ubiquitination.
Further studies confirm TRIM2-mediated Bim degradation as the mechanism of rapid ischemic tolerance-induced neuroprotection.
EXPERIMENTAL PROCEDURES

Drugs and Materials-
12-Otetradecanoylphorbol-13-acetate (TPA), Emetine hydrate dihydrochloride (Sigma); anti-Bim (rabbit monoclonal and polyclonal), phospho Bim (ser 69) total p42/p44 MAPK, phospho p42/p44 MAPK (thr202/ tyr 204) Cell Signaling Technologies; anti-TRIM2 Novus Biological (goat); anti-ubiquitin, GST, -tubulin, protein A agrose and protein G agarose beads (Santa Cruz Biochemicals).
Primary neuronal cell culture and oxygen glucose deprivation modeled ischemia-
Primary neuronal cultures are prepared from post natal day one rat pups of mixed sex, using a modification of the method described previously (27) . All experiments were performed in accordance with the American animal protection legislation and approved by the Legacy Health System Institutional Animal Care and Use Committee. Cortices are dissected from the pups chopped and incubated for 10 minutes in a papain solution (40 Units/ ml). Cells are dissociated in Dulbecco's modified Eagle's medium containing D-2-amino-5-phosphonovalerate (50 µM) and 10 % fetal bovine serum. Cells are grown in neurobasal A medium containing 1 % B27 supplement and 1 % glutamax. Media is replaced every 2-3 days. Cells are maintained in a humidified incubator (Forma Scientific) gassed with 5% CO 2 / 95% O 2 for 10-14 days in vitro (DIV). Cells are typically 80-90 % neuronal (NeuN positive) and the morphology is assessed on a batch of sister cultures using DiO staining as described in (6) .
Cultures showing signs of excitotoxicity are discarded (excessive membrane blebbing/ varicosities).
Ischemia is modeled by oxygen and glucose deprivation (OGD) as previously described (6) . Cells are removed from a normoxic incubator and washed twice with phosphate buffered saline (NaCl 1.37 mM, KCl 2.7mM, Na 2 HPO 4 10 mM, KH 2 PO 4 1.7 mM, pH 7.4) containing MgCl 2 (1.0 mM) and CaCl 2 (0.5 mM). Cells are placed into an anoxic chamber (Forma Scientific / ShelLabs Bactron) and maintained at 35 °C for the duration of the ischemic insult. Following ischemia, cells are replenished with normal neurobasal A media and returned to the normoxic incubator.
Proteomic identification of TRIM2-
GST Bim (Millipore) was phosphorylated by incubating with active p42/p44 MAPK (Erk1/2) (Millipore) for 30 min at 37 °C. Active MAPK was then removed by incubating with an excess of immobilized phospho-p42/p44 MAPK antibody (Cell Signaling). No active p42/p44 MAPK was detected following immunoprecipitation (Not shown). Phosphorylated GST Bim was then bound to glutathione sephrose beads (Amersham) for 30 min at room temp and then washed twice with PBS/ 0.1% NP40. Cells lystates were prepared from neuronal cells (1.0 mg), cleared, and then incubated for 2 hours at 4 °C with the phosphorylated GST Bim/ sepharose beads. MG132 was present during the incubation to prevent degradation of ubiquitinated Bim. The beads were separated by centrifugation and washed 3x with PBS/ 0.1 % NP40. The beads were boiled in loading buffer and released proteins were subjected to PAGE (poly acrylamide gel electrophoresis). Gel sections (approximate 10-30 kDa gel fragments) were analyzed at the proteomics facility at the Fred Hutchinson Cancer Research Center (Seattle, WA). Unstained gel slices were washed twice with water and "in-gel" protein digestion were carried out as described (28) , but omitting the reduction and alkylation steps. Samples were desalted using micro C18 ZipTips (Millipore) and dried, and resuspended in 5 microliters of 0.1% trifluoroacetic acid and analyzed by liquid chromatography electrospray ionization tandem mass spectrometry (LC/ESI MS/MS) with a LCQ "classic" mass spectrometer (ThermoElectron) using a previously described instrument configuration (29) . Data were collected in a data dependent mode in which a MS scan was followed by MS/MS scans of the three most abundant ions from the preceding MS scan. Mass spectrometry data were searched against rat or human IPI protein databases using the protein database search algorithm X!Tandem, false discovery rates were assigned using Peptide Prophet, and results were filtered and sorted using the Computational Proteomic Analysis System (https://proteomics.fhcrc.org/CPAS). A cut off criteria of Peptide Prophet minimum probability scores of >0.9 (false discovery rate of less than 5%) was used to filter the peptide identification results. The IPI data base of identified peptides was searched to identify proteins with either RING or HECT domain motifs. Only proteins containing a RING or HECT domain were considered for further analysis.
Mouse embryonic fibroblast cell culture and stimulationMouse embryonic fibroblast cultures are grown and maintained in Advanced DMEM with 10% FBS and 1% GlutaMax (Invitrogen). The cultures are split twice weekly at a 1:4 ratio and 6cm dishes are plated for experimentation. To split cultures .25% Trypsin/EDTA is added to the flasks for 3 to 6 minutes, or until cells visibly dislodge from the bottom of the flask. The cells are then transferred to another tube with Advanced DMEM containing FBS (10 %) and GlutaMax. Then the tube containing the cells and media is spun at 2000 rpm for 5 minutes. Once the spin is complete the supernatant is removed and the cell pellet is then re-suspended in the feeding media and plated back into flasks for cultivation or dishes for experimentation.
In order to stimulate MEF cells two protocols were used. The first is similar to that of Ley et al (11) whereby cells are starved of serum for 24 hours, pretreated with 10 µM emetine for 10 min prior to incubating with serum (10 % FCS) for 60 min. In the second protocol, cells are starved of serum for 24 hours. Then the cultures were stimulated using .10 nM TPA (Phorbol 12-myristate 13-acetate; Sigma) for one hour in the presence of 10 M emetine (pretreated for 10 min).
Immunoprecipitation-Cells are lysed in a buffer 150mM NaCl, 50mM Tris-HCl, 1.0% NP-40, 1mM EDTA containing protease inhibitors (aprotinin 1.0 µg/ ml, leupeptin 0.5 µg/ ml, pepstatin 1.0 µg/ ml, Phenylmethanesulfonyl fluoride 10 µg/ ml (Sigma)) and phosphatase inhibitor cocktail (Sigma) 10 µl/ ml. Cells are cleared 6000 rpm for 5 min at 4°C and protein levels determined using Bradford reagent. Protein levels are normalized to approximately 500 µg/ sample. For exogenous Bim IPs, samples are incubated with either Bim GST or Bim 3A GST (Millipore) for 20 minutes at 30 °C. Samples are then incubated with protein AAgarose beads pre-conjugated with anti-TRIM2 antibody (Novus). For endogenous Bim IPs, samples are incubated with rabbit monoclonal anti-Bim antibody (Cell Signaling) preconjugated to protein A beads (Santa cruz) with a bridging antibody (Active Motif: 10µl/ reaction). Samples are incubated with IP antibodies for one hour at room temperature. Proteins are precipitated by addition of 50 µl of protein-A agarose beads (Santa Cruz) followed by centrifugation at 1000 rpm for 1 min at 4 °C. Proteins are washed with PBS 0.1 % NP 40 before being boiled and subject to SDS polyacrylamide gel electrophoresis. Immunoprecipitation experiments were performed at least twice.
Immunoblotting-Samples for immunoblotting are lysed in a buffer (0.1M NaCl, 0.02M Tris-HCl, pH 7.6, 1mM EDTA, pH 8.0, 1.0% NP-40) containing protease inhibitors (aprotinin 1.0 µg/ ml, leupeptin 0.5 µg/ ml, pepstatin 1.0 µg/ ml, Phenylmethanesulfonyl fluoride 10 µg/ ml (Sigma)) and a phosphatase inhibitor cocktail (Sigma). Protein levels are determined using Bradford reagent and 50 µg samples of lysate are prepared. Samples are boiled in a sample loading buffer (0.14 M Tris-HCl, pH 6.8, 20 % glycerol, 2.2% SDS and 200mM DTT), quenched on ice for 1 minute and then loaded onto SDS polyacrylamide gels (10-15%-depending on experiment).
Proteins are transferred onto polyvinylidene fluoride membrane, blocked with Tris buffered saline containing 5 % non-fat milk or 0.1 % BSA for phopho-specific antibodies. Primary antibodies are incubated for two hours at room temperature, followed by washing in Tris buffered saline 0.1 % Tween 20. Secondary antibodies (Cell Signaling) are incubated at 1:2000 dilution for one hour at room temperature, followed by further washes. Membranes are incubated with chemiluminescence reagent (Visualizer, Upstate) for 2 minutes prior to digital determination of luminescence (Kodak 1D image station). Chemiluminescence was quantified using the Kodak 1D software.
Ubiquitination assay-Ubiquitination assays were performed according to manufacturer's instructions (BioMol).
Briefly normalized cell lysates were incubated with GST Bim, e1-Ligase, 11 E2 ligases, ATP, DTT MG132 and ubiquitin for 20 min at 37°C. Bim was immunoprecipitated with pre-conjugated anti-GST antibody (Santa Cruz) and proteins were immunoblotted and probed for ubiquitin.
c-myc-TRIM2 synthesis-The construct encoding the human cDNA TRIM2 (pGBK-T7-c-myc-TRIM2) was synthesized by amplification of the Human cDNA region encoding TRIM2 from pCMV-Sport6-TRIM2 (MHS1010-7429489; Clone ID 4156234; Open Biosystems, Huntsville, Al) using the inverse polymerase chain reaction method (Hemsley et al., 1989). The forward primer (gcc AAc ATA Tgg ccA gTg Aag gcA ccA Ac) introduced an NdeI restriction site at methionine 1. The reverse primer (gTc gAc cTg TAA gTA Tcg ATA gAc TTT gAA A) introduced a SalI restriction site at the stop codon (relative position amino acid 745). The amplified region was cloned 5' NdeI-3' SalI under control of the T7 promoter of pGBK-T7 (Clontech) and completely sequenced prior to use as a template. c-myc-TRIM2 was synthesized by in vitro transcription of the cDNA clone (pGBKT7-c-myc-TRIM2 ) using T7 RNA polymerase (Invitrogen). This was followed by in vitro translation in a nuclease-treated rabbit reticulosyte lysate system (Promega, Madison, WI) of the capped transcripts following previously described methods (Cleary et al. 2002) .
TRIM2 shRNA synthesis-We expressed four TRIM2 (NM_015271) specific Expression Arrest™ microRNAadapted shRNA (shRNAmir) vectors (V2LHS_80589, V2LHS_254587, V2LHS_80545, V2LHS_80547; Open Biosystems, Huntsville, Al) and one non-silencing-GIPZ lentiviral shRNAmir control (RHS4346) using the commercially available Trans-Lentiviral™ shRNA Packaging System (Open Biosystems, TLP4614). Manufacturers protocols were followed throughout; but briefly the day prior to transfection, HEK293T cells were plated at a density of 5.5 x 106. The following day a 1:5 DNA: Arrest-in transfection reagent ratio was used with serum-free DMEM (Invitrogen) growth media for transfection. After a 6hr incubation in a CO2 incubator at 37°C, 1ml of standard media was added to the cultures. Following a further 48hr incubation, the media was withdrawn and stored at 4°C, and fresh media applied to the cells for 24hrs (72hrs post-transfection). The growth media (from both 48 and 72hr time points) was then centrifuged at 3000 rpm for 20 mins (4°C). The supernatant was then ultracentrifuged at 73 800xg for 90 mins and the pellet resuspended in 250 µl serum-free DMEM growth media. This was centrifuged at 13 000 rpm for 5 min, prior to aliquoting. The prepared viral particles were then titered following manufacturers protocols throughout, prior to use at an MOI=10.
RESULTS
Proteomic identification of a phospho-Bim interacting
protein with the molecular signature of an E3-Ligase. A non-biased proteomic approach was used to identify Bim binding proteins with the molecular signature of an E3-Ligase (i.e. containing a RING or HECT domain). Since Bim ubiquitination is dependent on its phosphorylation by p42/p44 MAPK (11), we first phosphorylated GSTBim using exogenous activated p42/p44 MAPK (Millipore). Phosphorylation of the Bim was confirmed by immunoblotting with a phospho-Bim specific antibody (anti-phospho-Bim Ser55, Upstate: not shown). Lysates prepared from rat cortical neurons were incubated with phospho-Bim-GST bound to glutathioneconjugated agarose beads. Precipitated proteins were resolved by 10% SDS-PAGE (poly acrylamide gel electrophoresis) and gel sections subjected to proteomic analysis. Mass spectrometry data were analyzed using Pep-prophet and a criteria of a P value > 0.9 was selected.
Our mass spectrometry data identified two previously identified Bim binding proteins, dynein (15) and a 14-3-3 isoform (14-3-3 zeta) (16) (data not shown). Interestingly, only one peptide was identified which matched to a protein in the IPI database containing either a RING or HECT domain ( Figure. 1A) .
(NB the IPI database number for this peptide shown in fig one is no longer active). Blast searching the peptide sequence in Fig 1 revealed a 100 % match to the rat isoform of tri-partite motif protein 2 (TRIM 2). TRIM2 is a member of the TRIM family of RING domain containing E3-ligases (17) .
In order to confirm our observation, we performed an immunoprecipitation experiment in reverse of our proteomic experiment. We prepared a protein A agarose-immobilized TRIM2 antibody and incubated it with 500 µg rat brain lysate and GST-Bim. The blot was then probed with an anti-GST antibody (Santa Cruz). As a negative control, cells were incubated with protein A agarose beads. GST-Bim was immunoprecipitated from rat brain lysates using a TRIM2 antibody, hence confirming our observation that TRIM2 is a Biminteracting protein (Figure. 1B) .
Bim-TRIM2 interactions in a cell free expression system require p42/p44 MAPK.
We used a cell free transcription/ translation assay to confirm the binding of TRIM2 to Bim. C-myc tagged TRIM2 was synthesized by in vitro transcription/ translation of the cDNA clone (pGBKT7-TRIM2) ( Figure 1C) . As a positive control we also synthesized a c-myc tagged p53 binding domain (35 kDa translation product). Under basal conditions, cmyc TRIM2 weakly immunoprecipitated with GST-Bim ( Figure 1D) , however, the binding was stronger when active p42/p44 MAPK (Millipore) was added to the reaction ( Figure 1D ). Bim phosphorylation by p42/p44 MAPK was confirmed by immunoblotting with antibodies raised against phospho Ser65 Bim ( Figure  1D ). To show that the binding of TRIM2 with Bim was specific for phosphorylated Bim, we also incubated TRIM2 with the non-phosphorylatable mutant 3ABim and p42/p44 MAPK. The 3ABim mutant contains the following point mutations S55A, S65A and S73A. Binding of myc-TRIM2 with 3ABim in the presence of active MAPK was weak ( Figure 1D ). As a negative control, we performed an IP using the myc-p53. As can be seen in fig 3D, no binding of c-myc P53 was observed (Fig. 3D ). These data show that the binding of Bim to TRIM2 requires phosphorylation of Bim by p42/p44 MAPK on either Ser 55, 65 or 73.
TRIM2 interacts with Bim following p42/p44 MAPK activation in the mouse embryonic fibroblast cell line.
We used a mouse embryonic fibroblast (MEF) cell line to further investigate whether TRIM2 may function as a Bim E3-ligase. MEF cells have previously been used to study Bim ubiquitination (11, 18) . MEF cells express both Bim and our candidate Bim E3-ligase TRIM2. Under basal conditions MAPK activity in MEF cells is low, as determined by phospho p42/p44 MAPK levels ( Figure 2A ). Serum starvation of MEFs followed by serum stimulation has been shown to activate p42/p44 MAPK kinase and promote Bim ubiquitination (11, 14) . Phospho p42/p44 MAPK levels were increased following serum stimulation of cells, and Bim protein levels were decreased accordingly (Figure 2A) .
We next investigated whether TRIM2 interacts with Bim under conditions where Bim ubiquitination occurs. GST-Bim binding to TRIM2 increased in serum stimulated cells, compared to non-stimulated cells ( Figure. 2B ). When the non-phosphorylatable Bim mutant 3ABim was used in the immunoprecipitation reactions, we did not observe pulldown of 3ABim with TRIM2 in either control or stimulated cells ( Figure 2B ). This suggests that Bim degradation in MEF cells requires a p42/p44 MAPK-dependent interaction between Bim and TRIM2.
We further investigated the role of p42/p44 MAPK in regulating the interaction of Bim and TRIM2 using an additional stimulation of p42/p44 MAPK, Phorbol 12-myristate 13-acetate (TPA). Incubation of cells with TPA (10 nM; 1 hour) resulted in an increase in MAPK phosphorylation and reduced Bim protein levels ( Figure   2C 
, as well as MAPK phosphorylation was reduced in cells pretreated with U0126 (10 µM) prior to TPA stimulation ( Figure 2D ). Bim protein levels were increased in U0126 treated cells.
Immunoprecipitation of Bim with TRIM2 following preconditioning ischemia. Rapid ischemic tolerance was modeled in vitro, using 14 day rat cortical neurons subject to oxygen and glucose deprivation (OGD) ischemia, as previously described (1) (Figure. 3A) . Exposure to 30 min ischemia was not harmful, ( Figure. 3B) where as 120 min OGD induces approximately 50% cell death (P<0.001, 120 min OGD vs. control). Preconditioning cells with 30 min OGD, one hour prior to harmful ischemia, reduced cell death by 60% compared to cells subject to 120 min OGD alone (P<0.001 120 min OGD vs. 30+ 120 min OGD) ( Figure  3B ). We previously have shown that three proteasome
and clasto-lactacystin-lactone all block rapid ischemic tolerance (6) .
One hour following preconditioning ischemia Bim protein levels were decreased compared to control values (75.2 ± 6 % of control values (P<0.02, n=8, paired Students t-test of Log n transformed data) ( Figure 3C and (1) .
We used immunoprecipitation to determine whether TRIM2 binding to Bim correlates with the degradation of Bim following preconditioning ischemia. Both U0126 and MG132 stabilize Bim protein levels following preconditioning ischemia ( Figure 3C ) and (1). U0126 and MG132 had no affect on TRIM2 protein levels ( Figure 3C ). Phosphorylation of MAPK was increased following ischemia, and this increase was blocked by U0126 ( Figure 3C ). In contrast, blocking the proteasome with MG132, which also blocks preconditioning-induced Bim degradation, did not block the phosphorylation of p42/p44 MAPK ( Figure 3C ). We performed immunoprecipitations on preconditioned cell lysates incubated with GST-Bim. Binding of GST Bim to TRIM2 increased following preconditioning ( Figure 3D ). The binding of TRIM2 to GST-Bim following preconditioning ischemia was reduced in the presence of U0126, but not MG132 ( Figure 3D ).
In addition immunoprecipitation of endogenous Bim with TRIM2 increased following preconditioning ischemia and was blocked by U0126 (not shown).
As a final test of the MAPK sensitivity of the Bim/ TRIM2 interaction following preconditioning, we incubated control and preconditioned cell lysates with either GST-Bim, or the non-phosphorylatable 3ABim mutant. The immunoprecipitation of GST-Bim by TRIM2 was low in control cells, but increased one hour following 30 minutes preconditioning ischemia ( Figure  3E ). The immunoprecipitation of Bim with TRIM2 was blocked when cells were incubated with the nonphosphorylatable Bim mutant 3ABim ( Figure 3E ). This suggests that following preconditioning ischemia, Bim phosphorylation regulates the binding of Bim to TRIM2 in a manner consistent with the ubiquitination and degradation of Bim.
To further determine whether TRIM2 is the enzyme responsible for Bim ubiquitination following preconditioning ischemia, we investigated whether immunodepletion of TRIM2 from cell lysates prior to performing an ex-vivo ubiquitination assay would prevent Bim ubiquitination. Cell lysates were subjected to either TRIM2 immunodepletion, or control (CBP) immunodepletion prior to ubiquitination assay. TRIM2 immunodepletion was confirmed by immuno blot ( Figure 4A ). Bim ubiquitination was determined using an ex vivo ubiquitination assay (BioMol), whereby lysates were prepared incubated with biotinylatedubiquitin, GST-Bim, E1-and E2-ligases and ATP. Following termination of the reaction, the samples were subjected to GST immunoprecipitation and then immunoblotted for biotin. Following preconditioning there was an increase in Bim ubiquitination, as shown in Figure 4B ). Following immunodepletion of TRIM2 from the preconditioned cell lysates, Bim ubiquitination was reduced ( Figure 4B & C) . Taken together these data confirm that under conditions where Bim ubiquitination increases, Bim binds to the E3-ligase TRIM2 in a p42/p44 MAPK-dependent manner. Furthermore removal of TRIM2 from cell lysates prevents Bim ubiquitination following preconditioning ischemia.
Knockdown of TRIM2 using shRNA and its effect on rapid ischemic tolerance and Bim levels. We next examined whether loss of TRIM2 will increase Bim protein stability and block rapid ischemic tolerance. We used shRNAmir to knockdown TRIM2 expression. A lentivirus system delivered the shRNA plasmids to neurons. Cells were transduced for 48 hours with a MOI of 10 and transduction efficiency determined by GFP expression.
Incubation of cortical neurons with shRNA resulted in a 40% decrease in TRIM2 protein levels. We observed a corresponding 40% increase in Bim levels in the same cells ( Figure 5A) . We determined the effect of TRIM2 shRNA on preconditioning-induced Bim degradation. Following preconditioning ischemia, Bim levels were reduced in control plasmid treated cells, but not TRIM2 shRNAmir treated cells ( Figure 5B) . As a control we show that the increase in phospho-p42/p44 MAPK levels following preconditioning ischemia are not affected by shRNAmir treatment (Figure 5B) .
The effect of TRIM2 knockdown on neuronal sensitivity to ischemia was then examined. Cells were incubated with shRNAmir for 48 h and then subject to 30 and 120 min OGD, followed by 24 h recovery. As can be seen in Figure 5C , no significant differences were observe between silencing and non-silencing treated cells following either 30 min or 120 min OGD. However, knockdown of TRIM2 resulted in a loss of neuroprotection in neuronal cultures subjected to preconditioning ischemia and a subsequent harmful ischemic challenge ( Figure 5C ). This suggests that loss of TRIM2 blocks Bim degradation and rapid ischemic tolerance.
DISCUSSION
Here we propose that TRIM2 functions as a Bim E3-ligase following preconditioning ischemia, mediating the ubiquitination of the cell death protein Bim. Our candidate satisfies previously established criteria that show the interaction of Bim and TRIM2 is p42/p44 MAPK dependent. We show the p42/p44 MAPKdependent interaction between GST-Bim and exogenous TRIM2, synthesized in a cell free expression system (Fig  1) . In addition, we show, in two different cell lines (MEF cells and cultured rat neurons), that TRIM2 associates with Bim under conditions known to promote Bim ubiquitination. We show that serum stimulation or TPA stimulation of MEF cells increased the binding of Bim to TRIM2, in a MAPK dependent manner (Fig 2) . In cultured neurons subjected to brief ischemia Bim binding to TRIM2 increase consistent with Bim degradation (Fig 3) . The binding of Bim to TRIM2 was reduced when a non-phosphorylatable mutant Bim was used in the reactions. Finally, we show that knockdown of Bim by shRNAmir reduced Bim degradation and rapid ischemic tolerance (Fig 5) . Taken together these data support the role of TRIM2 as mediating p42/p44 MAPK-dependent Bim degradation following preconditioning ischemia.
We have previously reported that Bim ubiquitination is increased following preconditioning ischemia (1). We therefore determined whether TRIM2 may function as a Bim E3-ligase in this model. The binding of exogenous and endogenous Bim to TRIM2 was increased following preconditioning ischemia. Both exogenous (GST-bim) and endogenous Bim interactions with TRIM2 were investigated to take advantage of mutant Bim proteins with non-phosphorylatable residues. We observe a decrease in Bim binding to TRIM2 when p42/p44 MAPK activation is blocked. This observation is consistent with reports that Bim ubiquitination is p42/p44 MAPK-dependent (11) . Furthermore, TRIM2 did not precipitate the non-phosphorylatable mutant 3A Bim, which further supports a role of MAPK in regulating the interaction of Bim and TRIM2. When TRIM2 was immunodepleted from neuronal lysates we did not observe an increase in Bim ubiquitination following preconditioning ischemia. Therefore our identification of TRIM2 as a Bim E3-ligase is consistent with the known biology of Bim ubiquitination as reported by Simon Cook's group (11, 14) .
Our studies support the identification of TRIM2 as a Bim E3-ligase. TRIM2 is a member of the TRIM superfamily of E3 ligase proteins containing at least 37 members (19) . The proteins are so named because they contain a consensus RING domain, B-Box and coil coiled structures in their N-terminus. The RING domain is the molecular signature of the E3 ligase. Unlike other TRIM family proteins that contain two B-box domains, TRIM2 contains only one B-box domain, although the significance of this is as yet unclear (19) . Little functional data are available for TRIM2, or NARF since its identification as being induced following seizures in a kainate model of epilepsy (20) . Interestingly, Bim levels are regulated by seizures (10, 21) . It was shown that TRIM2 was associated with microtubule associated motor protein myosin V (20) . TRIM2 was also identified in a cancer genomic paper as being downregulated in cervical squamous cell carcinoma using gene chip microarrays, although further analysis with realtime RT-PCR show TRIM2 changes were not consistent (22) .
Recently, a TRIM2 knockout transgenic mouse was described (23) with features consistent with our hypothesis of TRIM2 regulating Bim degradation. The authors show that TRIM2 regulates neurofilament light chain ubiquitination and loss of TRIM2 promotes a neurodegenerative phenotype in mouse brain. Interestingly, the authors suggest that Ubc H5a regulates neurofilament light chain ubiquitination and TRIM2 auto-ubiquitination (23) .
In contrast our own preliminary studies suggest that UbcH5b regulates TRIM2-mediated ubiquitination of Bim (Meller unpublished observations). We therefore agree with the author's conclusion that multiple E2 proteins may regulate TRIM2 mediated protein ubiquitination. The observation of the neurodegeneration phenotype would be predicted if TRIM2 regulates ubiquitination of Bim, a regulator of neuronal cell death.
The role of neurofilament light chain in this mechanism is not yet clear, especially following preconditioning ischemia. While the authors did not measure Bim levels in their knockdown animals (23) , our experiments show that knockdown of TRIM2 increases endogenous Bim protein levels in neurons and blocks the preconditioning induced decrease in Bim (Fig 5) .
Two additional Bim E3 ligases have been proposed, CIS and c-Cbl (12, 13) . However, other studies fail to support their identification, for example Bim protein levels do not change in the testis of c-Cbl knockout mice, which would be expected if the E3-ligase were absent (24) . Bim levels increase following knockdown of TRIM2 (Fig 5) . c-Cbl is a tyrosine kinase, but mutation of all four tyrosine residues in Bim had no effect on Bim ubiquitination(14), whereas mutation of serine residues (Ser65) prevents Bim ubiquitination (11, 25) Serum stimulation of MEFs, which increases Bim ubiquitination, did not increase the interaction between Bim and c-Cbl (14). Finally, p42/p44 MAPKmediated Bim ubiquitination occurred in MEF cells obtained from c-Cbl knockout mice (14). A more recent candidate for the Bim E3 ligase is CIS, a member of the SKIP-Cullen E3-ligase family (13) . However, the authors did not show a p42/ p44 MAPK dependence of the interaction. Neither CIS, nor c-Cbl interacts with Bim in a manner consistent with Bim degradation following preconditioning ischemia (Supp data). Following preconditioning ischemia, we did not observe a significant increase in immunoprecipitation of CIS or c-Cbl with Bim. These data suggest that neither CIS, nor c-Cbl, mediate Bim ubiquitination following preconditioning, but does not rule out the potential role of these E3-ligases under alternative biological conditions. Interestingly, in our experiments we did observe an increase in c-Cbl binding to Bim in the presence of U0126, which is under further investigation (supp data).
We have recently described the role of the ubiquitinproteasome system in regulating rapid ischemic tolerance. The identification of the Bim E3-ligase in this system shows that the investigation of molecular mechanisms of rapid ischemic tolerance may yield novel therapeutic targets, which may help to reduce brain injury following ischemia. In addition these targets may enable the activation of a neuroprotective phenotype when ischemia may be predicted, such as occurs with heart bypass surgery. It is not yet clear whether TRIM2 acts on its own or in conjunction with other proteins to regulate Bim ubiquitination. While Bim phosphorylation of Ser69 is deemed necessary for the interaction between Bim and TRIM2, it is not yet clear whether this represents the binding sequence on Bim, or whether the phosphorylation of this residue results in a conformational change in the structure of Bim enabling its interaction with TRIM2. Some E3-ligase may also form dimers, which may be important for their function, but it is not yet clear whether TRIM2 acts in a similar manner. Finally, it is not yet clear which species of poly-ubiquitination TRIM2 modulates on the Bim protein. The ubiquitinated Bim is degraded by the proteasome, hence one would presume a K48 linkage poly-ubiquitin modification. Interestingly when TRIM2 is immunodepleted from cell lysates, we still observe a small increase in a lower molecular weight Bim (approx GST-Bim +1 ubiquitin), which may be indicative of mono-ubiquitination. It has been suggested that separate E3 ligases mediate mono and poly-ubiquitination of a substrate (26) . On the basis of our results TRIM2 may regulate poly-ubiquitination and function as an E4-ligase. However the distinction between E4 and E3 ligases is not clear, and TRIM2 contains a RING domain that is associated with E3 ligases, rather than the U-box domain of the E4-ligase. The identification of E3-and E4-ligases for a specific substrate may reveal additional targets for drug manipulation of the target protein.
The previous studies of Bim E3-ligases determined several criteria which they must satisfy to be considered a candidate Bim E3-ligase (14). TRIM2 satisfies these criteria for consideration as a Bim E3-ligase in multiple cell lines, using expressed proteins and following shRNAmir knockdown. Given the potential role of Bim in regulating apoptosis in many cells and pathological conditions, further knowledge of this enzyme offers the exciting potential of regulating Bim protein levels in cells as a therapeutic strategy.
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Cell death; E3 ubiquitin ligase; ERK; Ischemia; MAP kinases (MAPKs); Neurobiology; Neuron; Ubiquitin. Figure 1 . Proteomic identification of TRIM2 as a Bim binding protein and confirmation in a cell free transcription/ translation assay. A. Phospho-Bim binding proteins were precipitated from rat cortical neurons and subjected to 1D PAGE followed by mass spectroscopy. The peptide R.QTIIGQPMSVTITK.D was identified by mass spectrometry as a phospho-Bim binding protein. This peptide corresponds to the Rat homologue of TRIM2. Since this was the only E3 ligase protein identified, it was considered further. B. Binding of TRIM2 and Bim was confirmed by immunoprecipitation. Rat brain was incubated with GST-Bim and then subjected to TRIM2 immunoprecipitation. GST Bim was identified by immunoblotting precipitated proteins with a GST specific antibody. As a control the TRIM2 antibody was omitted from the reaction (-ve). C. Using a cell free expression system (Promega), TRIM2 and a control protein (p53 binding domain) DNA clones were synthesized into proteins. Expression was confirmed by immunoblotting lysate samples with a c-myc specific antibody. D. GST-Bim was incubated in the absence or presence of MAPK with either myc-TRIM2 or myc-P53. As a control, a non-phosphorylatable mutant bim (3ABim) was incubated with myc-TRIM2. Specific binding was determined by performing a GST pulldown and immunoblotting precipitated proteins for myc. Binding of myc-tagged TRIM2 increases when activated MAPK is added to the reaction. Incubation with a nonphosphorylatable BIM (3A Bim) reduces this interaction. E. the phosphorylation of Bim by MAPK was confirmed by blotting lysates with a phospho-Ser69 specific antibody. C. MEF cells were incubated with TPA for 1 hour and cell lysates prepared. Some cells were co-incubated with U0126 (10 µM). Bim protein levels and phospho-MAPK levels were determined by immunoblotting. D. Lysates from TPA treated MEF cells were subjected to endogenous Bim immunoprecipitation. Precipitated proteins were immunobloted for TRIM2 with a TRIM2 specific Antibody (Novus). TRIM2 pulldown with Bim increases following incubation of MEF cells with TPA and is reduced by U0126. Figure 3 . TRIM2 binding to Bim following preconditioning ischemia is dependent on Bim phosphorylation by p42/p44 MAPK. A. Schematic of the rapid ischemic tolerance paradigm. Neuronal cultures are subjected to preconditioning ischemia (30 min OGD: PC) 1 hour prior to harmful ischemia (120 min OGD). B. Viability was assessed in cultures subjected to 30 min, 120 min or 30 min followed by 1 hour recovery and a subsequent 120 min OGD. Cell death was assessed by propidium iodide assay 24 hours following the last ischemic event. PI positive cells are expressed as the percent of total (DAPI stained) cells in the culture. Data shown are mean ± sem n=12, * denotes P<0.001 vs. control and ** denotes P<0.001 vs. 120 min OGD (one -way ANOVA with Bonferroni post-hoc test). C. Cells were subjected to 30 min OGD preconditioning ischemia and then recovered in the presence of MG132 (10 µM) or U0126 (10µM) for 1 hour. TRIM2, Bim and phospho-MAPK levels were assessed using immunoblotting . E Cells were subjected to 30 min OGD preconditioning ischemia and then recovered in the presence of MG132 (10 µM) or U0126 (10µM) for 1 hour. Lysates were incubated with GST-Bim and then subjected to TRIM2 immunoprecipitation (TRIM2 IP). Precipitated proteins were immunoblotted with a GST specific antibody. Binding of Bim with TRIM2 increases following 30 min OGD, and is reduced by U0126. F. Cells were subjected to 30 min preconditioning ischema. Lysates were prepared and incubated with GST-Bim or GST-3ABim. Following TRIM2 immunoprecipitation (TRIM2 IP), precipitated proteins were immunoblotted with a GST specific antibody The pulldown of GST-Bim from cell lysates by TRIM2 (TRIM2 IP) is increased following preconditioning ischemia. Non-phosphorylatable 3ABim did not pull down. Figure 4 . Immunodepletion of TRIM2 from preconditioned neuronal lysates reduces Bim ubiquitination. Cell lysates from control and preconditioned cells (30 min OGD, 1hour recovery) were prepared and subjected to TRIM2 or control (CBP) immunodepletion. Antibodies raised against CBP or TRIM2 were bound to protein A/G agarose beads and incubated with prepared lysates. A. To confirm removal of TRIM2 from the lysate, a sample (5%) was subjected to immunoblotting with a TRIM2 specific antibody. B. Control and TRIM2 immunodepleted lysates were then used to measure Bim ubiquitination. Cell lysates were incubated with GST-Bim, biotinylated ubiquitin, E1 and E2 proteins. GST-Bim was precipitated by GST pulldown and the ubiquitinated precipitated proteins were immunoblotted with a biotin specific antibody. Preconditioning results in Bim ubiquitination in control (CBP) immunodepleted lysates, but not TRIM2 depleted lysates. The white dotted line denotes where image was cut and re-assembled to match the above lane loading. C Quantification of 3 independent experiments. Figure 5 . Lentiviral-mediated delivery of anti-TRIM2 shRNAmir reveals a role of TRIM2 in rapid ischemic tolerance-induced neuroprotection. A. Neuronal cells were incubated with control or anti-TRIM2 shRNAmir (MOI10, 48 hours). Cell lysates were prepared, and TRIM2 and Bim protein levels were determined by immunoblotting. B. Cells were incubated with either non-silencing control or TRIM2 silencing shRNAmir for 48 hours. Cells were then preconditioned with 30 min OGD and recovered for 1 hour. Bim protein levels and MAPK phosphorylation were determined by immunoblotting. Representative immunoblot for Bim and phosphorylated p42/p44 MAPK in TRIM2 knockdown cells and control cells subjected to 30 min OGD and one hour recovery. C. Cells were incubated with TRIM2 shRNAmir or non-silencing control for 48 hours. Cells were then subjected to 30 min, 120 min or 30 min followed by 1 hour recovery and a subsequent 120 min OGD. Cell death was assessed by propidium iodide assay 24 hours later. Data shown are mean ± sem n=5, ** denotes P<0.001 vs. non-silencing treated cells (2 -way ANOVA with Bonferroni post-hoc test). 
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